InvestSMART

Medlab Clinical Limited (ASX: MDC) - Announcements

DELISTED - Current share price for MDC : $6.600

ASX company news and announcements for Medlab Clinical Limited (MDC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Medlab Clinical Limited (MDC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Medlab Clinical Limited (MDC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Medlab Clinical Limited (MDC)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Response to ASX Query 5 May 2017 4:24PM $0.820 $6.600 risen by 704.88%
- Appendix 4C - quarterly 28 Apr 2017 11:58AM $0.830 $6.600 risen by 695.18%
- Letter to Shareholders 10 Apr 2017 9:46AM $0.830 $6.600 risen by 695.18%
- Investor Presentation 30 Mar 2017 9:04AM $0.930 $6.600 risen by 609.68%
- MEDLAB GRANTED ETHICS APPROVAL FOR PHASE 2A DEPRESSION STUDY 27 Mar 2017 9:27AM $0.870 $6.600 risen by 658.62%
- Medlab Signs Agreement to Start Comparison Study for Statins 6 Mar 2017 9:32AM $0.840 $6.600 risen by 685.71%
- December 2016 Financial Report 28 Feb 2017 9:30AM $0.835 $6.600 risen by 690.42%
- Shareholder Letter 28 Feb 2017 9:28AM $0.835 $6.600 risen by 690.42%
- Appendix 4D 28 Feb 2017 9:27AM $0.835 $6.600 risen by 690.42%
- Government Easing of Cannabis Supply as Medlab Trial Nears 22 Feb 2017 10:48AM $0.755 $6.600 risen by 774.17%
- Appendix 4C - quarterly 31 Jan 2017 11:16AM $0.800 $6.600 risen by 725%
- Breakthrough for Medlab - TGA Grants Licence for Cannabis 10 Nov 2016 9:20AM $0.640 $6.600 risen by 931.25%
- Media Release - Medlab Prepares to Start Cannabis Trial 7 Nov 2016 10:00AM $0.600 $6.600 risen by 1,000%
- AGM 2016 - Presentation 4 Nov 2016 9:54AM $0.590 $6.600 risen by 1,018.64%
- Results of Meeting 4 Nov 2016 12:33AM $0.590 $6.600 risen by 1,018.64%
- Appendix 4C - quarterly 31 Oct 2016 1:17PM $0.560 $6.600 risen by 1,078.57%
- Notice of Annual General Meeting/Proxy Form 5 Oct 2016 2:11PM $0.460 $6.600 risen by 1,334.78%
- Change of Director's Interest Notice 2 Sep 2016 3:39PM $0.390 $6.600 risen by 1,592.31%
- Appendix 4G 31 Aug 2016 1:33PM $0.370 $6.600 risen by 1,683.78%
- Annual Report to shareholders 31 Aug 2016 1:33PM $0.370 $6.600 risen by 1,683.78%
- Preliminary Final Report 31 Aug 2016 1:31PM $0.370 $6.600 risen by 1,683.78%
- Rights Issue - Issue of Shortfall Shares 30 Aug 2016 3:42PM $0.375 $6.600 risen by 1,660%
- Medlab Heading to Phase 2A with Anti-Depression Therapy 30 Aug 2016 8:24AM $0.375 $6.600 risen by 1,660%
- Medlab & Aphria Complete Cannabis Supply Agreement 22 Aug 2016 9:16AM $0.345 $6.600 risen by 1,813.04%
- Change of Director's Interest Notice x 2 17 Aug 2016 3:36PM $0.385 $6.600 risen by 1,614.29%

351 - 375 of 435 results

Page 15 of 18

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.